首页> 美国卫生研究院文献>Quantitative Imaging in Medicine and Surgery >The influence of CT and dual-energy X-ray absorptiometry (DXA) bone density on quantitative 18F sodium fluoride PET
【2h】

The influence of CT and dual-energy X-ray absorptiometry (DXA) bone density on quantitative 18F sodium fluoride PET

机译:CT和双能X线骨密度仪(DXA)骨密度对定量18F氟化钠PET的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background[18F] sodium fluoride PET/CT provides quantitative measures of bone metabolic activity expressed by the parameters standardised uptake value (SUV) and bone plasma clearance (Ki) that correlate with measurements of bone formation rate obtained by bone biopsy with double tetracycline labelling. Both SUV and Ki relate to the tracer uptake in each millilitre of tissue. In general, the bone region of interest (ROI) includes both mineralised bone {generally with a high concentration of [18F]NaF} and bone marrow (with a much lower concentration), suggesting that correcting SUV and Ki for volumetric bone mineral density (vBMD) and measuring them with respect to the tracer uptake in each gram of bone mineral might improve the correlation with the findings of bone biopsy. As a first test of this hypothesis, we looked for positive correlations between SUV and Ki values with CT and DXA bone mineral density (BMD) parameters measured in the same ROI.
机译:背景[ 18 F]氟化钠PET / CT提供了定量的骨代谢活动量度,该量度由参数标准化摄取值(SUV)和骨血浆清除率(Ki)表示,与获取的骨形成率相关通过双四环素标记的骨活检。 SUV和Ki都与每毫升组织中示踪剂的摄取有关。通常,感兴趣的骨区域(ROI)包括矿化的骨{通常具有高浓度的[ 18 F] NaF}和骨髓(具有低浓度的骨髓),这表明纠正SUV和Ki表示体积骨矿物质密度(vBMD),并针对每克骨矿物质中的示踪剂摄取量进行测量,可能会改善与骨活检结果的相关性。作为对该假设的首次检验,我们寻找了在相同ROI下测得的SUV和Ki值与CT和DXA骨矿物质密度(BMD)参数之间的正相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号